US Bancorp DE Purchases 10,379 Shares of IQVIA Holdings Inc. (NYSE:IQV)

US Bancorp DE grew its position in IQVIA Holdings Inc. (NYSE:IQV) by 62.2% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 27,061 shares of the medical research company’s stock after purchasing an additional 10,379 shares during the quarter. US Bancorp DE’s holdings in IQVIA were worth $6,413,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently modified their holdings of IQV. Park Place Capital Corp bought a new position in IQVIA in the 3rd quarter worth $28,000. Versant Capital Management Inc boosted its stake in shares of IQVIA by 733.3% in the second quarter. Versant Capital Management Inc now owns 125 shares of the medical research company’s stock worth $26,000 after acquiring an additional 110 shares during the period. Opal Wealth Advisors LLC purchased a new stake in shares of IQVIA during the second quarter worth about $27,000. Itau Unibanco Holding S.A. bought a new stake in IQVIA during the 2nd quarter valued at approximately $29,000. Finally, International Assets Investment Management LLC purchased a new position in IQVIA in the 2nd quarter worth approximately $32,000. 89.62% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other IQVIA news, insider Eric Sherbet sold 1,300 shares of the company’s stock in a transaction dated Tuesday, August 27th. The shares were sold at an average price of $246.33, for a total value of $320,229.00. Following the transaction, the insider now directly owns 19,536 shares in the company, valued at $4,812,302.88. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.60% of the stock is currently owned by insiders.

IQVIA Stock Performance

Shares of IQVIA stock opened at $209.16 on Monday. The company has a quick ratio of 0.85, a current ratio of 0.81 and a debt-to-equity ratio of 1.76. The stock’s fifty day moving average is $234.31 and its two-hundred day moving average is $229.76. IQVIA Holdings Inc. has a 52 week low of $181.03 and a 52 week high of $261.73. The company has a market capitalization of $38.13 billion, a PE ratio of 27.45, a price-to-earnings-growth ratio of 2.01 and a beta of 1.51.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on the stock. The Goldman Sachs Group reduced their price objective on shares of IQVIA from $280.00 to $250.00 and set a “buy” rating on the stock in a research report on Friday. Royal Bank of Canada reiterated an “outperform” rating and issued a $270.00 price target on shares of IQVIA in a research note on Friday. Truist Financial cut their price objective on IQVIA from $300.00 to $286.00 and set a “buy” rating for the company in a research report on Monday, October 14th. Evercore ISI dropped their price target on IQVIA from $270.00 to $265.00 and set an “outperform” rating for the company in a research note on Tuesday, October 8th. Finally, JPMorgan Chase & Co. reduced their price objective on IQVIA from $288.00 to $279.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 23rd. Four analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $263.81.

IQVIA Company Profile

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.